Paris, France

Stéphane Illiano

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Stéphane Illiano: Innovator in Therapeutic Peptides

Introduction

Stéphane Illiano is a prominent inventor based in Paris, France. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic peptides. With a total of six patents to his name, Illiano's work is paving the way for advancements in medical treatments.

Latest Patents

Among his latest patents, Illiano has developed modified lipidated relaxin B chain peptides and their therapeutic uses. One notable invention is a biologically active single chain relaxin peptide characterized by the formula N-Ac-L-E-G-R-E-K-V-R-A-X-I-X-X-E-G-X-S-T-F-S-X-R-A-X-NH-C, or a salt or solvate thereof. Another significant patent involves a similar biologically active single chain relaxin peptide with the formula N-Ac-(E)-X-E-G-R-E-X-V-R-X-X-I-X-X-E-G-X-S-X-X-X-X-R-(X)-(X)-(K)-(X)-(gE)-X-C, along with a pharmaceutical composition that includes at least one peptide of the invention for use as a medicament.

Career Highlights

Stéphane Illiano is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi focuses on innovative solutions in the pharmaceutical industry, particularly in the development of new therapeutic agents.

Collaborations

Illiano collaborates with notable colleagues such as Olivier Duclos and Sergio Mallart. These partnerships enhance the research and development efforts within his field, contributing to the advancement of therapeutic applications.

Conclusion

Stéphane Illiano's innovative work in the field of therapeutic peptides exemplifies the impact of dedicated research and collaboration in medicine. His contributions are vital for the future of medical treatments and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…